surmount-1 week 12 weight loss tirzepatide The New - SURMOUNT-1: In an RCT, adults with obesity treated with weekly had major over 72 weeks. #ADA2022 https://nej.md/3mjAbvD Adults with obesity using tirzepatide
Description
Tirzepatide on ingestive behavior in adults with overweight or obesity: A randomized 6-week phase 1 trial
Diabetes, Obesity, and Metabolism
The duration varies by individual and by the specific nature of the effect
Product arrived hot
Retatrutide may produce greater average weight loss than Mounjaro based on clinical trial data so far, but it is too early to say it is better overall
However, no significant difference in eGFR was observed between tirzepatide and comparators
